The results showed that ABCC8 mRNA expression was higher in patients with better prognosis indicators, such as oligodendroglioma (p = 1.4e−32), low WHO grade (p = 2.5e−23), IDH mutation (p = 6.4e−20), 1p/19q col-deletion (p = 7.3e−23) and low who molecular grade (2016) (p = 2.8e−35). This evidence concerns the gene IDH2 and oligodendroglioma.